Published on in Vol 11, No 2 (2022): Jul-Dec
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/38542, first published
.
![Use of Bacopa monnieri in the Treatment of Dementia Due to Alzheimer Disease: Systematic Review of Randomized Controlled Trials Use of Bacopa monnieri in the Treatment of Dementia Due to Alzheimer Disease: Systematic Review of Randomized Controlled Trials](https://asset.jmir.pub/assets/23a8b2680322451288279ffaf1e59538.png 480w,https://asset.jmir.pub/assets/23a8b2680322451288279ffaf1e59538.png 960w,https://asset.jmir.pub/assets/23a8b2680322451288279ffaf1e59538.png 1920w,https://asset.jmir.pub/assets/23a8b2680322451288279ffaf1e59538.png 2500w)
Journals
- Agarwal A, Mishra B, Gupta A, Srivastava M, Basheer A, Sharma J, Vishnu V. Importance of high-quality evidence regarding the use of Bacopa monnieri in dementia. Frontiers in Aging Neuroscience 2023;15 View
- Shoukat S, Zia M, Uzair M, Alsubki R, Sajid K, Shoukat S, Attia K, Fiaz S, Ali S, Kimiko I, Ali G. Synergistic neuroprotection by phytocompounds of Bacopa monnieri in scopolamine-induced Alzheimer’s disease mice model. Molecular Biology Reports 2023;50(10):7967 View
- Valotto Neto L, Reverete de Araujo M, Moretti Junior R, Mendes Machado N, Joshi R, dos Santos Buglio D, Barbalho Lamas C, Direito R, Fornari Laurindo L, Tanaka M, Barbalho S. Investigating the Neuroprotective and Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review Focused on Inflammation, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis. Antioxidants 2024;13(4):393 View